Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 4, 2025 • 7:00 AM ET
As of January 4, 2025 • 7:00 AM ET
Date/Time | Source | News Release |
---|---|---|
12/10/2024 02:00 PM EST | SeekingAlpha | Anixa Biosciences: Uncertainty In The Pipeline, Uncertainty In Their Financial Outlook |
11/22/2024 11:16 AM EST | SeekingAlpha | Anixa rises as board approves Bitcoin as a treasury reserve asset |
11/18/2024 10:21 AM EST | Baystreet | Anixa Hikes on Tests |
09/04/2024 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Wednesday, September 4th, 2024 |
09/04/2024 05:32 AM EDT | US Earnings Reports | Expected earnings - Anixa Biosciences Inc. |
08/09/2024 10:31 AM EDT | Zacks | Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated |
08/09/2024 10:20 AM EDT | Zacks | Cytokinetics (CYTK) Q2 Loss Wider Than Expected, Pipeline in Focus |
08/09/2024 09:45 AM EDT | Zacks | Gilead (GILD) Q2 Earnings Beat, Annual Profit Guidance Raised |
08/08/2024 09:55 AM EDT | Zacks | Kymera (KYMR) Q2 Loss Narrower Than Expected, Pipeline in Focus |
08/08/2024 09:54 AM EDT | Zacks | Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.